| Date Filed | Type | Description |
| 10/06/2023 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Bought 32,523 shares
@ $37.9316, valued at
$1.2M
Bought 97,474 shares
@ $37.9219, valued at
$3.7M
Bought 75,299 shares
@ $37.6156, valued at
$2.8M
|
|
| 04/05/2023 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 26,827,638 shares
@ $0.3017, valued at
$8.1M
|
|
| 02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/15/2022 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 6,003,752 shares
@ $1.3325, valued at
$8M
Granted 5,882 convertible preferred
@ $1.53, valued at
$9k
Granted convertible preferred
@ $1.53, valued at
$0
Granted 6,003,752 options to buy
@ $1.53, valued at
$9.2M
Granted options to buy
@ $1.53, valued at
$0 |
|
| 03/25/2022 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Lineage Cell Therapeutics, Inc.|
Txns:
| Bought 260,106 shares
@ $1.366, valued at
$355.3k
Bought 200,000 shares
@ $1.4217, valued at
$284.3k
Bought 470,000 shares
@ $1.4426, valued at
$678k
|
|
| 02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Sold 347,000 shares
@ $102.33, valued at
$35.5M
Sold 164,686 shares
@ $103.99, valued at
$17.1M
Sold 278,197 shares
@ $105.83, valued at
$29.4M
|
|
| 01/22/2021 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on OncoCyte Corp|
Txns:
| Bought 1,460,280 shares
@ $3.424, valued at
$5M
|
|
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/28/2020 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on OncoCyte Corp|
Txns:
| Bought 1,050,000 shares
@ $2.27, valued at
$2.4M
|
|
|